 | Up a level |
Journal Article
Jeryczynski, G., Albert, W., Gisslinger, B., Schalling, M., Burgstaller, S., Buxhofer-Ausch, V., Krauth, M. T., Geissler, K., Schloegl, E., Sliwa, T., Schiefer, A. I., Muellauer, L., Simonitsch-Klupp, I., Beham-Schmid, C., Thiele, J. and Gisslinger, H. (2016). A MULTICENTER EVALUATION OF THE REVISED 2015 WHO MINOR CRITERIA FOR PREFIBROTIC PRIMARY MYELOFIBROSIS. Haematologica, 101. S. 556 - 557. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078
Jeryczynski, G., Gisslinger, B., Schalling, M., Muellauer, L., Schiefer, A. -I., Thiele, J. and Gisslinger, H. (2015). CLINICAL IMPACT OF BONE MARROW MORPHOLOGY FOR THE DIAGNOSIS OF ESSENTIAL THROMBOCYTHEMIA: COMPARISON BETWEEN THE BRITISH STANDARDS (BCSH) AND THE WHO CRITERIA. Haematologica, 100. S. 260 - 261. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078
Schalling, M., Gisslinger, B., Jeryczynski, G., Berg, T., Harutyunyan, A., Milosevic, J., Bagienski, K., Them, N., Schischlik, F., Buxhofer-Ausch, V., Nirnberger, G., Schiefer, A. -I., Muellauer, L., Kralovics, R., Thiele, J. and Gisslinger, H. (2015). IMPACT OF CALR AND ASXL1 MUTATIONS ON SURVIVAL AND DISEASE COMPLICATIONS IN ESSENTIAL THROMBOCYTHEMIA AND PREFIBROTIC PRIMARY MYELOFIBROSIS STRICTLY DIAGNOSED ACCORDING TO THE WHO-CLASSIFICATION. Haematologica, 100. S. 262 - 263. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078